MDM2 expression during mammary tumorigenesis

被引：0
|
作者：
Pinkas, J
He, C
Jerry, DJ
Naber, SP
机构：
[1] Univ Massachusetts, Amherst, MA 01003 USA
[2] Tufts Univ, Sch Med, Baystate Med Ctr, Springfield, MA 01199 USA
来源：
MODERN PATHOLOGY | 1998年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：165A / 165A
页数：1
相关论文
共 50 条
  • [41] MDM2 SNP-309 Promoter Polymorphism, MDM2 and p53 Expression in Pancreatic Ductal Adenocarcinoma
    Zhou, X.
    Rock, J.
    McNally, M. E.
    Bloomston, M.
    Zhao, W.
    Lozanski, G.
    Frankel, W. L.
    [J]. MODERN PATHOLOGY, 2012, 25 : 450A - 450A
  • [42] Integration of DNA Damage and Repair with Murine Double-Minute 2 (Mdm2) in Tumorigenesis
    Lehman, Jason A.
    Mayo, Lindsey D.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (12) : 16373 - 16386
  • [43] Increased MDM2 expression is associated with inferior survival in mantle cell lymphoma, but not related to the MDM2 SNP309
    Hartmann, Elena
    Fernandez, Veronica
    Stoecklein, Heike
    Hernandez, Luis
    Campo, Elias
    Rosenwald, Andreas
    [J]. HAEMATOLOGICA, 2007, 92 (04) : 574 - 575
  • [44] The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor
    Eskandari, Mohammad
    Shi, Yang
    Liu, John
    Albanese, Joseph
    Goel, Swati
    Verma, Amit
    Wang, Yanhua
    [J]. LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 167 - 175
  • [45] FLT3 and MDM2 expression are biomarkers for combined MDM2 and MEK inhibition treatment in acute myeloid leukemia
    Seipel, K.
    Marques, M. A.
    Sidler, C.
    Mueller, B. U.
    Pabst, T.
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 24S - 24S
  • [46] MDM2 SNP-309 Promoter Polymorphism, MDM2 and p53 Expression in Pancreatic Ductal Adenocarcinoma
    Zhou, X.
    Rock, J.
    McNally, M. E.
    Bloomston, M.
    Zhao, W.
    Lozanski, G.
    Frankel, W. L.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 450A - 450A
  • [47] MDM2 gene amplification as a predictive biomarker for the MDM2 inhibitor milademetan
    Tirunagaru, Vijaya G.
    Gounder, Mrinal M.
    Kumar, Prasanna R.
    Hong, David S.
    Doebele, Robert C.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [48] Expression of Akt and Mdm2 in esophageal squamous cell carcinoma
    Takahashi, Ken
    Miyashita, Masao
    Makino, Hiroshi
    Nomura, Tsutomu
    Sasajima, Koji
    Yamashita, Kiyohiko
    Tajiri, Takashi
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [49] Expression of heparanase, Mdm2, and erbB2 in ovarian cancer
    Ginath, S
    Menczer, J
    Friedmann, Y
    Aingorn, H
    Aviv, A
    Tajima, K
    Dantes, A
    Glezerman, M
    Vlodavsky, I
    Amsterdam, A
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (06) : 1133 - 1144
  • [50] MDM2 expression in normal, hyperplasic and tumoral endometrium.
    Gutierrez, LS
    [J]. LABORATORY INVESTIGATION, 1997, 76 (01) : 584 - 584
12345